Legal Representation
Attorney
Tiffany D. Gehrke
USPTO Deadlines
Next Deadline
22 days remaining
Published for Opposition
Due Date
August 28, 2025
Extension Available
Until September 28, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 29, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 29, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 23, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 24, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 10, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 13, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 13, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Cells for medical or clinical use in the field of stem cell therapy for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes; pharmaceutical and biopharmaceutical agents for the treatment of diabetes
Class 042
gene editing, namely, pharmaceutical research and development in the field of stem cell therapy for the treatment of diabetes; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of stem cell therapy for the treatment of diabetes
Additional Information
Pseudo Mark
CTX TWO ONE THREE
Pseudo Mark
CTX TWO HUNDRED THIRTEEN
Classification
International Classes
005
042